102 related articles for article (PubMed ID: 27811505)
21. Malignant Insulinoma Arising From Nonfunctioning Pancreatic Neuroendocrine Tumor.
Chatterjee R; Ali B; Nguyen SH; Chen R; Sada YH
ACG Case Rep J; 2023 Jan; 10(1):e00954. PubMed ID: 38445216
[TBL] [Abstract][Full Text] [Related]
22. Consequences of Increases in Antibiotic Resistance Pattern on Outcome of Pancreatic Resection for Cancer.
Gianotti L; Tamini N; Gavazzi F; Mariani A; Sandini M; Ferla F; Cereda M; Capretti G; Di Sandro S; Bernasconi DP; De Carlis L; Zerbi A
J Gastrointest Surg; 2017 Oct; 21(10):1650-1657. PubMed ID: 28681215
[TBL] [Abstract][Full Text] [Related]
23. Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.
Mohindroo C; Baydogan S; Agarwal P; Wright RD; Prakash LR; Mork ME; Klein AP; Laheru DA; Maxwell JE; Katz MHG; Dasari A; Kim MP; He J; McAllister F; De Jesus-Acosta A
Cancer Prev Res (Phila); 2024 Apr; ():. PubMed ID: 38662083
[TBL] [Abstract][Full Text] [Related]
24. Bone phenotypes in multiple endocrine neoplasia type 1: survey on the MEN1 Florentine database.
Marini F; Giusti F; Iantomasi T; Cioppi F; Brandi ML
Endocr Connect; 2022 May; 11(5):. PubMed ID: 35324455
[TBL] [Abstract][Full Text] [Related]
25. Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.
Campa D; Obazee O; Pastore M; Panzuto F; Liço V; Greenhalf W; Katzke V; Tavano F; Costello E; Corbo V; Talar-Wojnarowska R; Strobel O; Zambon CF; Neoptolemos JP; Zerboni G; Kaaks R; Key TJ; Lombardo C; Jamroziak K; Gioffreda D; Hackert T; Khaw KT; Landi S; Milanetto AC; Landoni L; Lawlor RT; Bambi F; Pirozzi F; Basso D; Pasquali C; Capurso G; Canzian F
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1349-1351. PubMed ID: 28765340
[No Abstract] [Full Text] [Related]
26. Rescue from complications after pancreaticoduodenectomies at a low-volume Caribbean center: Value of tailored peri-pancreatectomy protocols.
Cawich SO; Dixon E; Shukla PJ; Shrikhande SV; Deshpande RR; Mohammed F; Pearce NW; Francis W; Johnson S; Bujhawan J
World J Gastrointest Surg; 2024 Mar; 16(3):681-688. PubMed ID: 38577074
[TBL] [Abstract][Full Text] [Related]
27. Exploring the Link Between Pancreatic Neuroendocrine Tumors and Depression: A Case Study.
Villa NAE; Fiore GMP; Espiridion ED
Cureus; 2023 Aug; 15(8):e44363. PubMed ID: 37779774
[TBL] [Abstract][Full Text] [Related]
28. Correction to: "Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review".
J Clin Endocrinol Metab; 2024 Jun; 109(7):e1563. PubMed ID: 38470411
[No Abstract] [Full Text] [Related]
29. Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm: Results From the DutchMEN1 Study Group.
Nell S; Verkooijen HM; Pieterman CRC; de Herder WW; Hermus AR; Dekkers OM; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
Ann Surg; 2018 Jun; 267(6):1155-1160. PubMed ID: 28257328
[TBL] [Abstract][Full Text] [Related]
30. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
[TBL] [Abstract][Full Text] [Related]
31. Lanreotide Therapy vs Active Surveillance in MEN1-Related Pancreatic Neuroendocrine Tumors < 2 Centimeters.
Faggiano A; Modica R; Lo Calzo F; Camera L; Napolitano V; Altieri B; de Cicco F; Bottiglieri F; Sesti F; Badalamenti G; Isidori AM; Colao A
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31586182
[TBL] [Abstract][Full Text] [Related]
32. Current and emerging therapies for PNETs in patients with or without MEN1.
Frost M; Lines KE; Thakker RV
Nat Rev Endocrinol; 2018 Apr; 14(4):216-227. PubMed ID: 29449689
[TBL] [Abstract][Full Text] [Related]
33. [Individualized approach for MEN1-associated duodenopancreatic neuroendocrine neoplasms].
Manoharan J; Albers MB; Bartsch DK
Chirurgie (Heidelb); 2024 Mar; 95(3):207-215. PubMed ID: 38180518
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries.
Tonelli F; Marini F; Giusti F; Iantomasi T; Giudici F; Brandi ML
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894286
[TBL] [Abstract][Full Text] [Related]
35. Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
van Vliembergen ENM; Eijkelenkamp H; Valk GD; Vriens MR; Meijer GJ; Intven MPW; de Laat JM
Front Endocrinol (Lausanne); 2023; 14():994370. PubMed ID: 37305036
[TBL] [Abstract][Full Text] [Related]
36. Treatment Outcome of Endoscopic Ultrasound Radiofrequency Ablation for Incidentaloma Pancreatic Neuroendocrine Tumor in Young Female Patient: A 2-year Follow-Up.
Lesmana CRA; Lirendra M; Inggriani S; Sudoyo AW; Lesmana L
Case Rep Gastroenterol; 2022; 16(3):583-587. PubMed ID: 36636359
[TBL] [Abstract][Full Text] [Related]
37. May the robotic approach expand the indications for redo surgery in recurrent pNETs in Multiple Neuroendocrine Neoplasia type 1?
Baz C; Dreifuss NH; Cubisino A; Schlottmann F; Mangano A; Aguiluz G; Vanetta C; Masrur MA; Giulianotti PC
J Surg Case Rep; 2022 Sep; 2022(9):rjac433. PubMed ID: 36158249
[TBL] [Abstract][Full Text] [Related]
38. Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger-Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1.
Kong W; Albers MB; Manoharan J; Goebel JN; Kann PH; Jesinghaus M; Bartsch DK
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454834
[TBL] [Abstract][Full Text] [Related]
39. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract][Full Text] [Related]
40. Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 Pancreatic Tumors: Experiences From a Single Tertiary Referral Center.
Calissendorff J; Bjellerup-Calissendorff F; Bränström R; Juhlin CC; Falhammar H
Front Endocrinol (Lausanne); 2021; 12():657698. PubMed ID: 33927695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
